CEN BIOTECH, INC.: 10-Q filed 2018-11-13
What CEN BIOTECH, INC. reported in its quarterly report filed 2018-11-13 (fiscal Q3 2018): 26 published measures, 71 facts as tagged in accession 0001437749-18-020484.
This filing
- Form
- 10-Q (quarterly report)
- Filed
- 2018-11-13
- Fiscal period
- fiscal Q3 2018
- Accession
- 0001437749-18-020484 on SEC EDGAR
Values are as tagged in this filing. A later filing can restate them; each measure links to its history page, which shows the latest-filed value per period. All CEN BIOTECH, INC. filings.
Reported measures
Total assets
Resources recognized on the balance sheet. Book assets are not the market value of the business.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2018-09-30 | 9,083,988 | USD | |
| At 2017-12-31 | 9,020,935 | USD |
Total liabilities
Recognized obligations at the reporting date. The definition and scope differ from interest-bearing debt.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2018-09-30 | 27,407,965 | USD | |
| At 2017-12-31 | 28,035,586 | USD |
Stockholders equity
The reported residual interest after liabilities. It is an accounting amount, not market capitalization.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2018-09-30 | -18,323,977 | USD | |
| At 2017-12-31 | -19,014,651 | USD | |
| At 2017-09-30 | -17,521,348 | USD | |
| At 2016-12-31 | -14,044,146 | USD |
Cash and cash equivalents
Cash and qualifying short-term liquid investments under the filer’s accounting policy. Restricted cash and longer-term investments may be reported separately.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2018-09-30 | 170,219 | USD | |
| At 2017-12-31 | 84,978 | USD | |
| At 2017-09-30 | 60,389 | USD | |
| At 2016-12-31 | 62,381 | USD |
Net income or loss
Reported profit or loss for the period. Check the filing for attribution, exceptional items and discontinued operations before comparing companies.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2018-07-01 to 2018-09-30 | -1,388,783 | USD | 92 |
| 2018-01-01 to 2018-09-30 | -4,369,094 | USD | 273 |
| 2017-07-01 to 2017-09-30 | -1,204,630 | USD | 92 |
| 2017-01-01 to 2017-09-30 | -3,477,202 | USD | 273 |
Operating cash flow
Cash generated or used by operating activities. Working-capital timing can make this differ substantially from reported income.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2018-01-01 to 2018-09-30 | -1,389,784 | USD | 273 |
| 2017-01-01 to 2017-09-30 | -1,319,601 | USD | 273 |
Financing cash flow
Net cash from financing activities, including borrowing, repayments and transactions with owners. A positive amount does not establish operating profitability.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2018-01-01 to 2018-09-30 | 1,580,464 | USD | 273 |
| 2017-01-01 to 2017-09-30 | 1,809,980 | USD | 273 |
Investing cash flow
Net cash from investing activities, including asset purchases, disposals and investment transactions. This differs from capital expenditure payments alone.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2018-01-01 to 2018-09-30 | -105,439 | USD | 273 |
| 2017-01-01 to 2017-09-30 | -492,371 | USD | 273 |
Retained earnings or deficit
Accumulated undistributed earnings or deficit at the reporting date. This balance is not cash available for distribution.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2018-09-30 | -32,493,786 | USD | |
| At 2017-12-31 | -28,124,692 | USD | |
| At 2017-09-30 | -17,521,440 | USD |
Net property, plant and equipment
Carrying amount of property, plant and equipment after accumulated depreciation, depletion and amortization. It is not replacement cost or market value.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2018-09-30 | 1,441,220 | USD | |
| At 2017-12-31 | 1,445,415 | USD |
Share-based compensation expense
Reported noncash expense for share-based payment arrangements. Noncash treatment does not mean the awards have no economic cost to shareholders.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2018-07-01 to 2018-09-30 | 167,400 | USD | 92 |
| 2018-01-01 to 2018-09-30 | 514,600 | USD | 273 |
Operating income or loss
Operating revenue less operating expenses for the reporting period. It excludes items outside the reported operating result and is not free cash flow.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2018-07-01 to 2018-09-30 | -640,055 | USD | 92 |
| 2018-01-01 to 2018-09-30 | -2,261,213 | USD | 273 |
| 2017-07-01 to 2017-09-30 | -550,695 | USD | 92 |
| 2017-01-01 to 2017-09-30 | -1,620,913 | USD | 273 |
Current liabilities
Obligations classified as current under the operating-cycle or one-year boundary. The balance includes more than short-term borrowing.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2018-09-30 | 23,210,887 | USD | |
| At 2017-12-31 | 20,027,393 | USD |
Current accounts payable
Current amounts owed to suppliers for goods and services received. This is one component of current liabilities, not all accrued obligations.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2018-09-30 | 219,692 | USD | |
| At 2017-12-31 | 104,828 | USD |
Net finite-lived intangible assets
Finite-lived intangible assets after amortization. This excludes goodwill and should not be combined with indefinite-lived intangible assets without checking scope.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2018-09-30 | 5,911,974 | USD | |
| At 2017-12-31 | 6,230,583 | USD |
Operating expenses
Recurring operating costs under this accounting concept, generally excluding production costs included in cost of sales. Check filing presentation before combining expense subtotals.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2018-07-01 to 2018-09-30 | 640,055 | USD | 92 |
| 2018-01-01 to 2018-09-30 | 2,261,213 | USD | 273 |
| 2017-07-01 to 2017-09-30 | 550,695 | USD | 92 |
| 2017-01-01 to 2017-09-30 | 1,620,913 | USD | 273 |
Common shares outstanding
Common shares outstanding at the reporting date. This point-in-time count differs from the weighted-average shares used for earnings per share and can exclude other share classes.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2018-09-30 | 25,418,243 | shares | |
| At 2017-12-31 | 25,131,843 | shares |
Additional paid-in capital
Capital contributed above par value under this concept. It records historical contributions, not the current value of the equity or cash on hand.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2018-09-30 | 14,169,809 | USD | |
| At 2017-12-31 | 9,110,041 | USD | |
| At 2017-09-30 | 82 | USD |
Accumulated depreciation on property, plant and equipment
Cumulative depreciation, depletion and amortization recorded against property, plant and equipment. It measures cost allocation to date, not physical wear or market value.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2018-09-30 | 12,726 | USD | |
| At 2017-12-31 | 3,092 | USD |
Net intangible assets excluding goodwill
Intangible assets other than goodwill after amortization and impairment. Internally developed intangibles are usually not recognized, so this understates what a company relies on.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2018-09-30 | 5,911,974 | USD | |
| At 2017-12-31 | 6,230,583 | USD | |
| At 2017-09-30 | 6,336,787 | USD |
Accrued current liabilities
Current obligations accrued for goods and services received but not yet invoiced or paid. This is one component of current liabilities, not all short-term obligations.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2018-09-30 | 371,177 | USD | |
| At 2017-12-31 | 295,874 | USD |
General and administrative expense
General and administrative costs reported under this concept, separate from selling expense. Filers group overhead differently, so compare presentation before comparing companies.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2018-07-01 to 2018-09-30 | 355,441 | USD | 92 |
| 2018-01-01 to 2018-09-30 | 1,491,875 | USD | 273 |
| 2017-07-01 to 2017-09-30 | 357,053 | USD | 92 |
| 2017-01-01 to 2017-09-30 | 1,145,944 | USD | 273 |
Depreciation expense
Depreciation recognized for the period under this concept. It is a noncash allocation of asset cost and may exclude amortization and depletion reported elsewhere.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2018-07-01 to 2018-09-30 | 4,596 | USD | 92 |
| 2018-01-01 to 2018-09-30 | 9,634 | USD | 273 |
| 2017-07-01 to 2017-09-30 | 442 | USD | 92 |
| 2017-01-01 to 2017-09-30 | 1,325 | USD | 273 |
Nonoperating income or expense
Total nonoperating income or expense, which can include interest, investment results and other items. A positive value is not operating profit.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2018-07-01 to 2018-09-30 | -748,728 | USD | 92 |
| 2018-01-01 to 2018-09-30 | -2,107,881 | USD | 273 |
| 2017-07-01 to 2017-09-30 | -653,935 | USD | 92 |
| 2017-01-01 to 2017-09-30 | -1,856,289 | USD | 273 |
Interest paid, net
Cash interest paid during the period, net of amounts capitalized where the filer reports it that way. It differs from interest expense recognized.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2018-01-01 to 2018-09-30 | 33,055 | USD | 273 |
| 2017-01-01 to 2017-09-30 | 68,129 | USD | 273 |
Change in accounts payable
The cash flow adjustment for the change in payables during the period. A positive value under this concept means payables grew and added to operating cash flow.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2018-01-01 to 2018-09-30 | 109,454 | USD | 273 |
| 2017-01-01 to 2017-09-30 | -147,052 | USD | 273 |
Inspect the source
- Entity
- CEN BIOTECH, INC. / CIK 0001653821
- Captured
- SEC response SHA-256
097c84c6c785c728d94a8aab95d5185c6c0595b9a921b7610327e115a19292be
Current SEC company facts · Download the original response snapshot (gzip) · Download the selected JSON
Every published concept a filing tagged, with the periods it covered, as reported in that filing at capture time. Forms 10-K, 10-K/A, 10-Q, 10-Q/A, 20-F, 20-F/A, 40-F, 40-F/A. A filing page needs at least 8 published concepts. Later filings can restate these values; the company history pages show the latest-filed value per period.
Public company accounting reference, not market prices, returns, an investment recommendation, or ALPHAC performance. Validate a separately constructed return series with the validation API; accounting values are not returns.
Use this in research
A financial period ends before its results become public. Use the filing date as a minimum availability boundary, inspect amendments, and retain the original filing vintage when testing historical signals. This latest-filed selection can contain information unavailable at the time.
These pages do not supply prices, total-return histories, corporate-action adjustments or a tradable universe. Build those inputs separately before evaluating a strategy. A profitable backtest can still reflect selection bias or costs that were left out.
Research methodology · Execution and cost assumptions · Check backtest overfitting
Build with the open-source tools
Use these accounting records as inspectable inputs. When you have constructed a return series, the validation tools can help test its statistical evidence and preserve the result with its limitations.
- Get an API key and run your first validation
- Connect the MCP server to your coding assistant
- Inspect the ALPHAC engine on GitHub
- Read the MCP server source and integration examples
Read the published dataset with Python
import json
from urllib.request import urlopen
with urlopen("https://canlicapital.com/company-data/0001653821.json") as response:
record = json.load(response)
print(record["fetched_at"])
print(record["policy"])
for concept in record["concepts"]:
print(concept["tag"], next(iter(concept["observations"])))